[{"address1": "852 Winter Street", "address2": "Suite 250", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 271 2954", "website": "https://zenasbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 130, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leon Oliver Moulder Jr., M.B.A.", "age": 67, "title": "CEO & Chairman of the Board", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 686554, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph L. Farmer", "age": 52, "title": "COO & President", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 757454, "exercisedValue": 0, "unexercisedValue": 274230}, {"maxAge": 1, "name": "Ms. Jennifer A. Fox", "age": 52, "title": "Chief Business Officer & CFO", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 856021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Orlando  Oliveira", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 509897, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Haley  Laken Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Held", "age": 55, "title": "Chief Legal Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Chevalier", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tanya Z. Fischer M.D., Ph.D.", "title": "Head of Research & Development and Chief Medical Officer.", "fiscalYear": 2024, "totalPay": 332542, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lisa  von Moltke M.D.", "age": 65, "title": "Head of Research & Development and Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.76, "open": 29.29, "dayLow": 25.8, "dayHigh": 29.73, "regularMarketPreviousClose": 27.76, "regularMarketOpen": 29.29, "regularMarketDayLow": 25.8, "regularMarketDayHigh": 29.73, "payoutRatio": 0.0, "volume": 567481, "regularMarketVolume": 567481, "averageVolume": 240490, "averageVolume10days": 448890, "averageDailyVolume10Day": 448890, "bid": 25.58, "ask": 27.59, "bidSize": 3, "askSize": 3, "marketCap": 1252663168, "fiftyTwoWeekLow": 5.83, "fiftyTwoWeekHigh": 29.73, "allTimeHigh": 29.73, "allTimeLow": 5.83, "priceToSalesTrailing12Months": 83.51088, "fiftyDayAverage": 18.8505, "twoHundredDayAverage": 11.8021, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 847442240, "forwardPE": -5.128255, "profitMargins": 0.0, "floatShares": 18825837, "sharesOutstanding": 47110313, "sharesShort": 5616578, "sharesShortPriorMonth": 5760485, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.13340001, "heldPercentInsiders": 0.189, "heldPercentInstitutions": 0.70701, "shortRatio": 18.85, "shortPercentOfFloat": 0.19569999, "impliedSharesOutstanding": 47110313, "bookValue": 5.693, "priceToBook": 4.670648, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -177007008, "trailingEps": -12.29, "enterpriseToRevenue": 56.496, "enterpriseToEbitda": -4.484, "52WeekChange": 0.41737735, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 26.59, "targetHighPrice": 45.0, "targetLowPrice": 24.0, "targetMeanPrice": 34.28571, "targetMedianPrice": 31.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 273279008, "totalCashPerShare": 6.49, "ebitda": -188996992, "totalDebt": 1008000, "quickRatio": 5.157, "currentRatio": 5.233, "totalRevenue": 15000000, "debtToEquity": 0.421, "revenuePerShare": 0.45, "returnOnAssets": -0.47943002, "returnOnEquity": -0.88403, "grossProfits": -145628992, "freeCashflow": -85224128, "operatingCashflow": -148407008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.6067295, "financialCurrency": "USD", "symbol": "ZBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1760140702, "regularMarketTime": 1760126400, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1762864200, "earningsTimestampEnd": 1762864200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.29, "epsCurrentYear": -3.515, "priceEpsCurrentYear": -7.5647225, "fiftyDayAverageChange": 7.7395, "fiftyDayAverageChangePercent": 0.41057268, "twoHundredDayAverageChange": 14.7879, "twoHundredDayAverageChangePercent": 1.2529888, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "longName": "Zenas BioPharma, Inc.", "shortName": "Zenas BioPharma, Inc.", "exchange": "NMS", "messageBoardId": "finmb_1815193886", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.2147, "regularMarketPrice": 26.59, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.488902, "postMarketPrice": 26.72, "postMarketChange": 0.129999, "regularMarketChange": -1.17, "regularMarketDayRange": "25.8 - 29.73", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 240490, "fiftyTwoWeekLowChange": 20.76, "fiftyTwoWeekLowChangePercent": 3.560892, "fiftyTwoWeekRange": "5.83 - 29.73", "fiftyTwoWeekHighChange": -3.1399994, "fiftyTwoWeekHighChangePercent": -0.1056172, "fiftyTwoWeekChangePercent": 41.737736, "displayName": "Zenas BioPharma", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]